Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Ram Mukunda

Ram Mukunda is recorded as CEO and Board Member at IGC Pharma, Inc. (IGC). IGC Pharma, Inc. reported in an 8-K filed September 9, 2022 that Ram Mukunda was appointed Class C director, effective September 9, 2022. The proxy statement of IGC Pharma, Inc. reports total compensation of $568 for Ram Mukunda in fiscal 2025, including a base salary of $396. Disclosed compensation is on record for 7 fiscal years.

“On September 9, 2022, Ram Mukunda and Congressman James Moran were elected to India Globalization Capital's (the "Company") Board of Directors at the 2022 Annual Meeting of Stockholders (the "Annual Meeting"), to serve as Class C directors, until the 2025 annual meeting of stockholders”
IGC Pharma, Inc. Form 8-K, filed September 9, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at IGC Pharma, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 IGC Pharma, Inc. (IGC) $396 $568
2024 IGC Pharma, Inc. (IGC) $360 $1,821
2023 IGC Pharma, Inc. (IGC) $360 $1,006
2022 IGC Pharma, Inc. (IGC) $320 $5,547
2021 IGC Pharma, Inc. (IGC) $292 $801
2020 IGC Pharma, Inc. (IGC) $300,000 $719,000
2019 IGC Pharma, Inc. (IGC) $300,000 $712,000

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.